跳至主要内容
临床试验/NCT01381640
NCT01381640撤回1 期

A Single Dose Pharmacoscintigraphic Study Investigating the Differences in Gastrointestinal Behavior and Paracetamol Absorption Between Sustained Release Formula and Standard Release Formula

GlaxoSmithKline2 个研究点 分布在 1 个国家开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
试验地点
2
主要终点
Time of onset and completion of disintegration based on release of radiolabeled markers in a fed condition

研究概览

简要总结

This is a single dose pharmacoscintigraphic study investigating the differences in paracetamol absorption between two formulations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male subjects who are in good general health
  • Have not exceeded the limits of total radiation exposure (5mSv) allowed in any 12 month period

排除标准

  • 未提供

研究组 & 干预措施

Experimental paracetamol formulation

Experimental

Experimental formulation

干预措施: Experimental paracetamol formulation (Drug)

Marketed paracetamol

Active Comparator

Marketed formulation

干预措施: Marketed paracetamol (Drug)

结局指标

主要结局

Time of onset and completion of disintegration based on release of radiolabeled markers in a fed condition

时间窗: Baseline to 12 hours post dosing

次要结局

  • To assess the gastrointestinal transit by qualitative scintigraphic analysis(Baseline to 12 hours post dosing)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验